PD-L1 expression might be the crucial prognostic factors for EGFRm resectable NSCLC which probably help the clinicians to select the most benefit patients for adjuvant EGFR-TKI treatment in developing countries. Here, EGFR is linked to non-small cell lung carcinoma.